The press service of Roszdravnadzor noted that there is no shortage of drugs for international generic names in Russia, the temporary absence of a certain trade name in a pharmacy is not a sign of shortage, because drugs with one active substance have a therapeutic effect. exactly the same. It has been reported DEA News.
The Ministry emphasized that currently in Russian pharmacies there are sufficient quantities of drugs with the names “Osteogenon” and “Mesalazine”, which are not internationally registered.
The publication states that in the first three months of 2023, more than 58 thousand packages of Osteogenon and 383.8 thousand packages of Mesalazine entered civil circulation.
Former Deputy Minister of Health of Russia Sergey Glagolev declarationthat there is no shortage of drugs for active substances in the Russian Federation, although there are some trade names.
He noted that the Ministry of Health, in conjunction with the Ministry of Industry and Trade and the country’s government, “provides a real-time inventory of vital and essential medicines.”
Source: Gazeta
Barbara Dickson is a seasoned writer for “Social Bites”. She keeps readers informed on the latest news and trends, providing in-depth coverage and analysis on a variety of topics.